Sign in

CIK 0001868279 · Non-accelerated filer<br>Emerging growth company

ArriVent BioPharma, Inc.

Sign in to watch
Ticker
AVBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
240-780-6356
Business address
18 CAMPUS BLVD., SUITE 100, NEWTOWN SQUARE, PA, 19073-3269
  1. 8-A12B Other Registration of Securities
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. S-1/A Offering Registration Statement
  6. UPLOAD Other SEC-generated Letter
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. S-1 Offering Registration Statement
  9. DRS/A Other Draft Registration Statement
  10. DRSLTR Other Correspondence Related to Draft Registration Statement
  11. UPLOAD Other SEC-generated Letter
  12. DRSLTR Other Correspondence Related to Draft Registration Statement
  13. DRS/A Other Draft Registration Statement
  14. UPLOAD Other SEC-generated Letter
  15. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  16. DRSLTR Other Correspondence Related to Draft Registration Statement
  17. DRS/A Other Draft Registration Statement
  18. UPLOAD Other SEC-generated Letter
  19. DRS Other Draft Registration Statement
  20. D Other Notice of Sales of Unregistered Securities

Page 8 of 9 · 162 filings